US Patent 11389541 Sustained delivery of angiopoetin-like 3 polypeptides
Patent 11389541 was granted and assigned to Novartis on July, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11389541 Sustained delivery of angiopoetin-like 3 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
